Invention Grant
US08114989B2 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
失效
用作酪氨酸激酶抑制剂的吡唑基氨基嘧啶衍生物
- Patent Title: Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
- Patent Title (中): 用作酪氨酸激酶抑制剂的吡唑基氨基嘧啶衍生物
-
Application No.: US12713777Application Date: 2010-02-26
-
Publication No.: US08114989B2Publication Date: 2012-02-14
- Inventor: Bin Wang , Tao Wang
- Applicant: Bin Wang , Tao Wang
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Main IPC: C07D401/04
- IPC: C07D401/04
Abstract:
This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
Public/Granted literature
- US20100210648A1 PYRAZOLYLAMINOPYRIMIDINE DERIVATIVES USEFUL AS TYROSINE KINASE INHIBITORS Public/Granted day:2010-08-19
Information query
